Suppression of glomerular and renal hypertrophy in diabetes induced in angiotensin II type 1a receptor-deficient mice.

被引:0
|
作者
Okamoto, K
Kashihara, N
Sugiyama, H
Sekikawa, T
Maeshima, Y
Kanao, K
Sato, M
Maruyama, K
Makino, H
Sugaya, T
Hisada, Y
Murakami, K
机构
[1] OKAYAMA UNIV, SCH MED, OKAYAMA 700, JAPAN
[2] TANABE SEIYAKU CO LTD, LEAD GENERAT RES LABS, OSAKA, JAPAN
[3] UNIV TSUKUBA, TSUKUBA ADV RES ALLIANCE, INST APPL BIOCHEM, IBARAKI, OSAKA, JAPAN
来源
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A3150 / A3150
页数:1
相关论文
共 50 条
  • [1] Suppression of phenotypic alteration of mesangial cells in diabetes induced in angiotensin II type 1a receptor deficient mice.
    Okamoto, K
    Kashihara, N
    Sugiyama, H
    Sekikawa, T
    Maeshima, Y
    Kanao, K
    Sato, M
    Maruyama, K
    Odawara, M
    Kasahara, J
    Sugaya, T
    Murakami, K
    Makino, H
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3004 - A3004
  • [2] Angiotensin II type 1A receptor-deficient mice are protected against angiotensin II-mediated glomerular injury and cardiac hypertrophy.
    Maruyama, K
    Kashihara, N
    Sugiyama, H
    Okamoto, K
    Kanao, K
    Maeshima, Y
    Satoh, M
    Sekikawa, T
    Makino, H
    Sugaya, T
    Murakami, K
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1439 - A1439
  • [3] Renal interstitial fibrosis with unilateral ureteral obstruction is reduced in angiotensin II type 1a receptor-deficient mice.
    Satoh, M
    Kashihara, N
    Sugiyama, H
    Okamoto, K
    Kanao, K
    Maeshima, Y
    Maruyama, K
    Sekikawa, T
    Ogura, T
    Makino, H
    Sugaya, T
    Murakami, K
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A2588 - A2588
  • [4] Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice
    Satoh, M
    Kashihara, N
    Yamasaki, Y
    Maruyama, K
    Okamoto, K
    Maeshima, Y
    Sugiyama, H
    Sugaya, T
    Murakami, K
    Makino, H
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2001, 12 (02): : 317 - 325
  • [5] ANGIOTENSIN-II TYPE 1A RECEPTOR-DEFICIENT MICE WITH HYPOTENSION AND HYPERRENINEMIA
    SUGAYA, T
    NISHIMATSU, SI
    TANIMOTO, K
    TAKIMOTO, E
    YAMAGISHI, T
    IMAMURA, K
    GOTO, S
    IMAIZUMI, K
    HISADA, Y
    OTSUKA, A
    UCHIDA, H
    SUGIURA, M
    FUKUTA, K
    FUKAMIZU, A
    MURAKAMI, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (32) : 18719 - 18722
  • [6] Reduced angiogenesis and delay in wound healing in angiotensin II type 1a receptor-deficient mice
    Kurosaka, Maya
    Suzuki, Tatsunori
    Hosono, Kanako
    Kamata, Yuji
    Fukamizu, Akiyoshi
    Kitasato, Hidero
    Fujita, Yoshikuni
    Majima, Masataka
    BIOMEDICINE & PHARMACOTHERAPY, 2009, 63 (09) : 627 - 634
  • [7] A severe kidney phenotype in AT(1A) receptor-deficient mice.
    Oliverio, MI
    Best, CF
    Smithies, O
    Coffman, TM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A1878 - A1878
  • [8] Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice
    Ichihara, Atsuhiro
    Suzuki, Fumiaki
    Nakagawa, Tsutomu
    Kaneshiro, Yuki
    Takemitsu, Tomoko
    Sakoda, Mariyo
    Nabi, A. H. M. Nurun
    Nishiyama, Akira
    Sugaya, Takeshi
    Hayashi, Matsuhiko
    Inagami, Tadashi
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (07): : 1950 - 1961
  • [9] Angiotensin II type 1a receptor-deficient mice develop angiotensin II-induced oxidative stress and DNA damage without blood pressure increase
    Zimnol, Anna
    Amann, Kerstin
    Mandel, Philipp
    Hartmann, Christina
    Schupp, Nicole
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2017, 313 (06) : F1264 - F1273
  • [10] Angiotensin type 1a receptor-deficient mice develop diabetes-induced cardiac dysfunction, which is prevented by renin-angiotensin system inhibitors
    Yong, Qian Chen
    Thomas, Candice M.
    Seqqat, Rachid
    Chandel, Niketa
    Baker, Kenneth M.
    Kumar, Rajesh
    CARDIOVASCULAR DIABETOLOGY, 2013, 12